Refining Multimodal Therapy for Mesothelioma: Clinical Impact of SMART Sequencing episode artwork

EPISODE · Sep 9, 2025 · 5 MIN

Refining Multimodal Therapy for Mesothelioma: Clinical Impact of SMART Sequencing

from Conference Coverage

Guest: John Cho, MD, PhD, FRCPC Surgery for mesothelioma after radiation therapy (SMART) offers new hope for patients with resectable epithelioid mesothelioma by reversing the traditional treatment sequence. Hear from Dr. John Cho as he discusses the rationale behind this decade-long clinical advancement, which he spoke about at the 2025 World Conference on Lung Cancer. Dr. Cho is a radiation oncologist at Princess Margaret Cancer Centre and an Associate Professor in the Department of Radiation Oncology at the University of Toronto.

Episode metadata supplied by the publisher feed · Published Sep 9, 2025

Embed this episode

NOW PLAYING

Refining Multimodal Therapy for Mesothelioma: Clinical Impact of SMART Sequencing

0:00 5:00

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Conference Coverage?

This episode is 5 minutes long.

When was this Conference Coverage episode published?

This episode was published on September 9, 2025.

Can I download this Conference Coverage episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!